1 |
Kato M, Arce L, Natarajan R. MicroRNAs and their role in progressive kidney diseases [J]. Clin J Am Soc Nephrol, 2009,4(7): 1255-1266.
|
2 |
Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight [J]. Nat Rev Genet, 2008, 9(2): 102-114.
|
3 |
Kim VN. MicroRNA biogenesis: coordinated cropping and dicing[J]. Nat Rev Mol Cell Biol, 2005, 6(5): 376-385.
|
4 |
Bartel DP. MicroRNAs: target recognition and regulatory functions [J]. Cell, 2009, 136(2): 215-233.
|
5 |
Grimson A, Farh KK, Johnston WK, et al. MicroRNA targeting specificity in mammals: determinants beyond seed pairing [J].Mol Cell, 2007, 27(1): 91-105.
|
6 |
Chendrimada TP, Finn KJ, Ji X, et al. MicroRNA silencing through RISC recruitment of eIF6 [J]. Nature, 2007, 447(7146): 823-828.
|
7 |
Sen GL, Blau HM. Argonaute 2/RISC resides in sites of mammalian mRNA decay known as cytoplasmic bodies [J]. Nat Cell Biol, 2005, 7(6): 633-636.
|
8 |
Kim DH, Saetrom P, Snove O Jr, et al. MicroRNA-directed transcriptional gene silencing in mammalian cells [J]. Proc Natl Acad Sci U S A, 2008, 105(42): 16230-16235.
|
9 |
Liu CG, Calin GA, Meloon B, et al. An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues [J]. Proc Natl Acad Sci U S A, 2004, 101(26): 9740-9744.
|
10 |
Tian Z, Greene AS, Pietrusz JL, et al. MicroRNA-target pairs in the rat kidney identified by microRNA microarray, proteomic, and bioinformatic analysis [J]. Genome Res, 2008, 18(3): 404-411.
|
11 |
Harvey SJ, Jarad G, Cunningham J, et al. Podocyte-specific deletion of dicer alters cytoskeletal dynamics and causes glomerular disease [J]. J Am Soc Nephrol, 2008, 19(11): 2150-2158.
|
12 |
Ho J, Ng KH, Rosen S, et al. Podocyte-specific loss of functional microRNAs leads to rapid glomerular and tubular injury [J]. J Am Soc Nephrol, 2008, 19(11): 2069-2075.
|
13 |
Shi S, Yu L, Chiu C, et al. Podocyte-selective deletion of dicer induces proteinuria and glomerulosclerosis [J]. J Am Soc Nephrol,2008, 19(11): 2159-2169.
|
14 |
Agrawal R, Tran U, Wessely O. The miR-30 miRNA family regulates Xenopus pronephros development and targets the transcription factor Xlim1/Lhx1 [J]. Development, 2009, 136(23):3927-3936.
|
15 |
Sequeira-Lopez ML, Weatherford ET, Borges GR, et al. The microRNA-processing enzyme dicer maintains juxtaglomerular cells [J]. J Am Soc Nephrol, 2010, 21(3): 460-467.
|
16 |
Adler S. Diabetic nephropathy: Linking histology, cell biology,and genetics [J]. Kidney Int, 2004, 66(5): 2095-2106.
|
17 |
Krupa A, Jenkins R, Luo DD, et al. Loss of MicroRNA-192 promotes fibrogenesis in diabetic nephropathy [J]. J Am Soc Nephrol, 2010, 21(3): 438-447.
|
18 |
Kato M, Putta S, Wang M, et al. TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN [J]. Nat Cell Biol, 2009, 11(7): 881-889.
|
19 |
Kato M, Zhang J, Wang M, et al. MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors [J]. Proc Natl Acad Sci U S A, 2007, 104(9): 3432-3437.
|
20 |
Du B, Ma LM, Huang MB, et al. High glucose down-regulates miR-29a to increase collagen IV production in HK-2 cells [J].FEBS Lett, 2010, 584(4): 811-816.
|
21 |
Wang Q, Wang Y, Minto AW, et al. MicroRNA-377 is upregulated and can lead to increased fibronectin production in diabetic nephropathy [J]. FASEB J, 2008, 22(12): 4126-4135.
|
22 |
Wei Q, Bhatt K, He HZ, et al. Targeted deletion of Dicer from proximal tubules protects against renal ischemia-reperfusion injury [J]. J Am Soc Nephrol, 2010, 21(5): 756-761.
|
23 |
Godwin JG, Ge X, Stephan K, et al. Identification of a microRNA signature of renal ischemia reperfusion injury [J]. Proc Natl Acad Sci U S A, 2010, 107(32): 14339-14344.
|
24 |
Bhatt K, Zhou L, Mi QS, et al. MicroRNA-34a is induced via p53 during cisplatin nephrotoxicity and contributes to cell survival [J].Mol Med, 2010, 16(9-10): 409-416.
|
25 |
Harris PC. Molecular basis of polycystic kidney disease: PKD1,PKD2 and PKHD1 [J]. Curr Opin Nephrol Hypertens, 2002,11(3): 309-314.
|
26 |
Lee SO, Masyuk T, Splinter P, et al. MicroRNA15a modulates expression of the cell-cycle regulator Cdc25A and affects hepatic cystogenesis in a rat model of polycystic kidney disease [J]. J Clin Invest, 2008, 118(11): 3714-3724.
|
27 |
Donadio JV, Grande JP. IgA nephropathy [J]. N Engl J Med,2002, 347(10): 738-748.
|
28 |
Wang G, Kwan BC, Lai FM, et al. Intrarenal expression of microRNAs in patients with IgA nephropathy [J]. Lab Invest,2010, 90(1): 98-103.
|
29 |
Wang G, Kwan BC, Lai FM, et al. Expression of microRNAs in the urinary sediment of patients with IgA nephropathy [J]. Dis Markers, 2010, 28(2): 79-86.
|
30 |
Williams AE, Perry MM, Moschos SA, et al. Role of miRNA-146a in the regulation of the innate immune response and cancer[J]. Biochem Soc Trans, 2008, 36(Pt 6): 1211-1215.
|
31 |
Wang G, Kwan BC, Lai FM, et al. Elevated levels of miR-146a and miR-155 in kidney biopsy and urine from patients with IgA nephropathy [J]. Dis Markers, 2011, 30(4): 171-179.
|
32 |
Lu J, Kwan BC, Lai FM, et al. Glomerular and tubulointerstitial miR-638, miR-198 and miR-146a expression in lupus nephritis [J].Nephrology (Carlton), 2012, 17(4): 346-351.
|
33 |
Kaelin WG Jr. The von Hippel-Lindau tumor suppressor gene and kidney cancer [J]. Clin Cancer Res, 2004, 10(18 Pt 2):6290S-6295S.
|
34 |
Neal CS, Michael MZ, Rawlings LH, et al. The VHL-dependent regulation of microRNAs in renal cancer [J]. BMC Med, 2010, 8: 64.
|
35 |
McCormick R, Buffa FM, Ragoussis J, et al. The role of hypoxia regulated microRNAs in cancer [J]. Curr Top Microbiol Immunol,2010, 345: 47-70.
|
36 |
White NM, Yousef GM. MicroRNAs: exploring a new dimension in the pathogenesis of kidney cancer [J]. BMC Med, 2010, 8: 65.
|
37 |
Kort EJ, Farber L, Tretiakova M, et al. The E2F3-Oncomir-1 axis is activated in Wilms' tumor [J]. Cancer Res, 2008, 68(11): 4034-4038.
|
38 |
Drake KM, Ruteshouser EC, Natrajan R, et al. Loss of heterozygosity at 2q37 in sporadic Wilms' tumor: putative role for miR-562 [J]. Clin Cancer Res, 2009, 15(19): 5985-5992.
|
39 |
Ambros V. The evolution of our thinking about microRNAs [J].Nat Med, 2008, 14(10): 1036-1040.
|
40 |
Lee NS, Dohjima T, Bauer G, et al. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells [J]. Nat Biotechnol, 2002, 20(5): 500-505.
|
41 |
Ebert MS, Neilson JR, Sharp PA. MicroRNA sponges:competitive inhibitors of small RNAs in mammalian cells [J]. Nat Methods, 2007, 4(9): 721-726.
|
42 |
Elmen J, Lindow M, Schutz S, et al. LNA-mediated microRNA silencing in non-human primates [J]. Nature, 2008, 452(7189):896-899.
|
43 |
Thum T, Gross C, Fiedler J, et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts [J]. Nature, 2008, 456(7224): 980-984.
|
44 |
Liu G, Friggeri A, Yang Y, et al. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis [J]. J Exp Med, 2010, 207(8): 1589-1597.
|
45 |
Gottardo F, Liu CG, Ferracin M, et al. Micro-RNA profiling in kidney and bladder cancers [J]. Urol Oncol, 2007, 25(5): 387-392.
|
46 |
Huang Y, Dai Y, Yang J, et al. Microarray analysis of microRNA expression in renal clear cell carcinoma [J]. Eur J Surg Oncol,2009, 35(10): 1119-1123.
|
47 |
Dai Y, Sui W, Lan H, et al. Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients [J].Rheumatol Int, 2009, 29(7): 749-754.
|
48 |
Wang G, Kwan BC, Lai FM, et al. Elevated levels of miR-146a and miR-155 in kidney biopsy and urine from patients with IgA nephropathy [J]. Dis Markers, 2011, 30(4): 171-179.
|
49 |
Sun H, Li QW, Lv XY, et al. MicroRNA-17 post-transcriptionally regulates polycystic kidney disease-2 gene and promotes cell proliferation [J]. Mol Biol Rep, 2010, 37(6): 2951-2958.
|
50 |
Xiao C, Srinivasan L, Calado DP, et al. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes [J]. Nat Immunol, 2008, 9(4): 405-414.
|
51 |
Zhang Z, Peng H, Chen J, et al. MicroRNA-21 protects from mesangial cell proliferation induced by diabetic nephropathy in db/db mice [J]. FEBS Lett, 2009, 583(12): 2009-2014.
|
52 |
Duisters RF, Tijsen AJ, Schroen B, et al. miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling [J]. Circ Res, 2009,104(2): 170-178.
|
53 |
Kato M, Zhang J, Wang M, et al. MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors [J]. Proc Natl Acad Sci U S A, 2007, 104(9): 3432-3437.
|
54 |
Faraoni I, Antonetti FR, Cardone J, et al. miR-155 gene: a typical multifunctional microRNA [J]. Biochim Biophys Acta, 2009,1792(6): 497-505.
|
55 |
Wang Q, Wang Y, Minto AW, et al. MicroRNA-377 is upregulated and can lead to increased fibronectin production in diabetic nephropathy [J]. FASEB J, 2008, 22(12): 4126-4135.
|